Tenon Medical closed a $3 million private placement with one institutional backer, selling 597,610 common shares or pre-funded warrants alongside warrants for up to 1,058,517 additional common shares. The combined price was $5.02 per share and warrant package, or $5.019 for each pre-funded warrant package; pre-funded warrants carry a $0.001 exercise price. The accompanying warrants are immediately exercisable at $5.02 and expire five years after issuance. Tenon expects approximately $3 million in gross proceeds before placement-agent fees and other offering expenses. The financing exceeds the company’s reported $1.677 million in cash and equivalents as of June 30, 2026, although net proceeds will be lower after costs. TNON fell 4.79% to $4.7606 in trading. WallachBeth Capital acted as exclusive placement agent. The securities were sold under Section 4(a)(2) of the Securities Act and/or Regulation D, with customary registration rights and resale restrictions. If exercised, the warrants could provide additional capital while increasing Tenon’s outstanding share count and diluting existing holders.